CClinicalTrials.gg
Enrolling by invitationNCT07401368Updated Aug 5, 2026

Clinicians' Trust in AI-Based Fetal Growth Estimates

An interventional study of Intervention - AI Performance Information in Fetal Growth, Obstetric Ultrasonography and Pregnancy, sponsored by Rigshospitalet, Denmark. Enrolling by invitation at 1 site in Denmark. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Sex
All
01

Study summary

This study examines how clinicians trust and use artificial intelligence (AI) when estimating fetal weight during pregnancy.

Accurate assessment of fetal growth is important for identifying growth problems that may affect pregnancy management. New AI-based tools can estimate fetal weight from ultrasound images, but little is known about how clinicians trust these estimates or how uncertainty information influences their decisions.

In this study, clinicians will review anonymized ultrasound cases and compare fetal weight estimates generated by an AI model with traditional estimates. Some clinicians will also be shown information about the AI model's performance and uncertainty, while others will not.

Participants will be asked to choose which estimate they find most reliable, indicate their level of confidence, and decide whether they would recommend follow-up scans. The study aims to better understand how AI and uncertainty information affect clinical decision-making and trust among clinicians with different levels of experience.

Read the detailed description

This is a randomized, matched, vignette-based questionnaire study designed to investigate clinicians' trust in and use of AI-based fetal growth estimates.

Clinicians from obstetrics and gynecology departments will be recruited and stratified by experience level. Participants will be randomized to either a control group or an intervention group. The intervention group will receive brief information about the AI model's overall performance, while the control group will not receive this information.

Each participant will assess a set of anonymized third-trimester ultrasound cases. For each case, clinicians will be presented with standard ultrasound images and relevant clinical context. They will be shown fetal weight estimates generated by an AI-based model and by a traditional biometric method, with or without accompanying uncertainty information in the form of confidence intervals.

For each case, clinicians will select the estimate they consider most clinically reliable, rate their confidence in that choice, and indicate whether they would recommend a follow-up growth scan. Case sets are matched by clinical experience, ensuring that identical cases are evaluated by clinicians with similar backgrounds across study arms.

The study focuses on clinicians as participants and involves no patient intervention. All ultrasound data are fully anonymized. The results will provide insight into how AI-generated estimates and uncertainty information influence clinical trust, preferences, and decision-making in fetal growth assessment.

02

Conditions studied

  • Fetal Growth
  • Obstetric Ultrasonography
  • Pregnancy
  • Clinical Decision-making

Keywords

  • Clinical decision-making
  • Artificial intelligence
  • Fetal weight estimation
  • Obstetric ultrasound
  • Trust
  • Human-AI interaction
  • Questionnaire study
03

In context

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Clinicians working in obstetrics and gynecology departments.
  • Regular use of obstetric ultrasound in clinical practice.
  • Willingness to participate in a questionnaire-based study.

Exclusion criteria

Exclusion Criteria:

  • Clinicians who do not perform obstetric ultrasound examinations.
  • Clinicians with a known conflict of interest related to the AI system being evaluated.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
130 participants (estimated)

Study arms

  • No intervention
    Control - No AI Performance Information

    Participants complete the questionnaire without receiving information about the AI model's overall performance.

  • Other
    ntervention - AI Performance Information

    Participants receive brief information about the AI model's overall performance before completing the questionnaire.

    Other: Intervention - AI Performance Information

Interventions

  • OtherIntervention - AI Performance Information

    Participants receive brief information about the AI model's overall performance before completing the questionnaire.

06

What researchers measure

Primary outcomes

  1. Clinicians' choice of fetal weight estimation method

    The proportion of cases in which clinicians choose the AI-based fetal weight estimate rather than the traditional Hadlock estimate when assessing anonymized ultrasound cases.

    Time frame: Immediately after questionnaire completion

Secondary outcomes

  1. Clinicians' confidence in selected fetal weight estimate

    Clinicians' self-reported confidence in the selected fetal weight estimate, measured on a 7-point Likert scale for each case.

    Time frame: Immediately after questionnaire completion

  2. Recommendation of follow-up growth scan

    Whether clinicians recommend a follow-up fetal growth scan based on the selected fetal weight estimate, recorded as a binary outcome (yes/no).

    Time frame: Immediately after questionnaire completion

  3. Impact of uncertainty information on model preference

    Difference in clinicians' preference for AI-based versus traditional fetal weight estimates when AI predictions are presented with versus without uncertainty information.

    Time frame: Immediately after questionnaire completion

07

Study locations

1 site
  • Department of Obstetrics and Gynecology, Slagelse Hospital
    Slagelse, 4200, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07401368
Lead sponsor
Rigshospitalet, Denmark
Collaborators
Slagelse Hospital, Copenhagen Academy for Medical Education and Simulation
Responsible party
Zahra Bashir (Dr., Rigshospitalet, Denmark) — Principal investigator
First posted
Feb 10, 2026
Start date
Apr 27, 2026
Primary completion
Dec 1, 2027 (estimated)
Completion
Dec 1, 2028 (estimated)
Last update
Aug 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion